Seasonal influenza vaccine

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

BRCA1/2 Flu Vaccine

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

Improved Novel VaccIne CombinaTion InflUenza Study

MTX Discontinuation and Vaccine Response

Two-site Intradermal Influenza Vaccination in Elderly

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine

Persistence of Immune Response After Vaccination With Influenza Vaccine

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)